Moderna

Yahoo Finance • 12 hours ago

Notable healthcare headlines for the week: Sanofi, Eli Lilly, and Novo Nordisk in focus

U.S. stocks rallied over the trading week, shortened by the Thanksgiving holiday and a reduced trading session on Friday. The S&P 500 was up around 4% during the week, while the Dow rose a similar amount and the tech-focused Nasdaq Compos... Full story

Yahoo Finance • yesterday

FDA official Prasad says COVID shot deaths mean stricter vaccine approval standards

[Doctor Vaccinating Little Girl Close Up] SeventyFour/iStock via Getty Images Vinay Prasad, the head of the US FDA's Center for Biologics Evaluations and Research which oversees vaccines, said that future vaccine approvals will face stric... Full story

Yahoo Finance • 5 days ago

Vaccine critic selected as CDC deputy director

[CDC Headquarters] hapabapa Ralph Abraham, Louisiana's surgeon general, is the CDC's next deputy director. _The Washington Post_, which broke [https://www.washingtonpost.com/health/2025/11/25/cdc-new-deputy-vaccine-ralph-abraham/] the de... Full story

Yahoo Finance • 6 days ago

Moderna is the S&P 500's most shorted stock: Here's why

President Trump is expected to unveil plans to lower healthcare costs, which could significantly impact the pharmaceutical industry. Additionally, Pfizer's (PFE) entry into the weight-loss drug space, joining Novo Nordisk (NVO) and Eli Lil... Full story

Yahoo Finance • 8 days ago

Notable healthcare headlines for the week: Abbott, Medtronic, Merck and J&J in focus

Wall Street staged a rebound on Friday, closing the session in positive territory after a turbulent, tech-driven downturn rattled the Nasdaq Composite just a day earlier. Friday's market boost was supported by reports that the Trump admin... Full story

Yahoo Finance • 9 days ago

Washington state resident dies from bird flu strain never before detected in humans

[Bird Flu Quarantine Tape Barrier Before Defocused Background] MicroStockHub The Washington State Department of Health has announced that H5N5, a bird flu strain that has never been detected in humans globally, led to the death of an olde... Full story

Yahoo Finance • 10 days ago

Sector Update: Health Care Stocks Softer Late Afternoon

Health care stocks declined late Thursday afternoon with the NYSE Health Care Index and the Health C PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 12 days ago

Moderna completes end-to-end mRNA manufacturing network in U.S.

[Massachusetts Based Biotech Company Moderna Receives FDA Approval To Continue Coronavirus Vaccine Trials] Maddie Meyer/Getty Images News Moderna (MRNA [https://seekingalpha.com/symbol/MRNA]) announced on Wednesday that it has completed i... Full story

Yahoo Finance • 16 days ago

Most shorted S&P 500 stocks in October

[short sale sign] Gunter_Nezhoda Moderna (MRNA [https://seekingalpha.com/symbol/MRNA]) retained its spot as the most shorted S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500]) stock as a percentage of float in October, followed by Ch... Full story

Yahoo Finance • 17 days ago

Pfizer CEO Albert Bourla says aggressive bid for Metsera reflects company's 'right to win' obesity market

Pfizer (PFE) CEO and chairman Albert Bourla told Yahoo Finance that the $10 billion acquisition of GLP-1 maker Metsera (MTSR) is part of the Big Pharma company's "right to win" in the obesity drug game. Pfizer competitor Novo Nordisk (NVO... Full story

Yahoo Finance • 22 days ago

Notable healthcare headlines for the week: Pfizer, Novo Nordisk, Moderna in focus

Wall Street major averages posted weekly loses amid an AI-tech trade that continued to struggle, with lower consumer sentiment, and the ongoing U.S. government shutdown. Week to date, the Nasdaq and S&P 500 were down 3% and 1.6%, respecti... Full story

Yahoo Finance • 22 days ago

Most S&P 500 healthcare stocks deliver earnings beat this week

21 out of 60 S&P 500 health care companies reported quarterly results this week, of which 20 delivered an earnings beat, and one came in-line with estimates. 16 of the reporting companies exceeded revenue consensus, while five trailed exp... Full story

Yahoo Finance • 24 days ago

India Coronavirus Vaccine Research Report 2025: $1.25 Bn Market Opportunities, Competition, Forecasts 2020-2030 - Expanding Healthcare in Tier 2 and 3 Cities, and Innovations in MRNA Technology

Company Logo India's Coronavirus Vaccine Market offers growth through government-led initiatives, robust manufacturing, and R&D in vaccine types. Opportunities arise from vaccine diplomacy, expanding healthcare in Tier 2 and 3 cities, and... Full story

Yahoo Finance • 24 days ago

December 26th Options Now Available For Moderna (MRNA)

Investors in Moderna Inc (Symbol: MRNA) saw new options begin trading today, for the December 26th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRNA options chain for the new December 26th contr... Full story

Yahoo Finance • 24 days ago

Moderna Cuts Costs As Covid Vaccine Sales Decline; Shares Rise

Moderna stock surged Thursday after the Covid vaccine-maker significantly cut its third-quarter costs, and still managed to easily beat sales expectations. Continue Reading View Comments... Full story

Yahoo Finance • 24 days ago

Moderna Tightens 2025 Revenue Outlook as Third-Quarter Top-Line Beats Estimates

Moderna (MRNA) narrowed its full-year revenue outlook on Thursday as the drugmaker's third-quarter t PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 24 days ago

Stock market today: Dow, S&P 500, Nasdaq waver as layoffs jump, key Tesla vote looms

US stocks roughly wavered early Thursday as concerns about Big Tech continued to dog markets and private jobs data showed a tough month for layoffs in October. The S&P 500 (^GSPC) and the Dow Jones Industrial Average (^DJI) both held near... Full story

Yahoo Finance • 25 days ago

Moderna trims top end of full-year forecast on weak COVID vaccine sales

By Patrick Wingrove (Reuters) -Moderna lowered the top end of its 2025 revenue forecast by $200 million on Thursday, citing weaker-than-expected sales of its COVID-19 vaccine in the U.S. as Americans struggled to access the shots. The co... Full story

Yahoo Finance • 25 days ago

Stock market today: Dow, S&P 500, Nasdaq futures tick down with Supreme Court tariff case, Tesla shareholder meeting in focus

US stock futures wobbled below the baseline Wednesday night, as investors weighed easing concerns over lofty AI valuations and drew optimism from a Supreme Court hearing that hinted at a possible setback for President Donald Trump’s tariff... Full story

Yahoo Finance • 26 days ago

Nucleic Acid Therapeutics Market Report 2025: Competition Intensifies as Pfizer, Sanofi, Novartis, Moderna, BioNTech Expand Antisense and RNA Platform Innovations - Long-term Forecast to 2029 & 2034

Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Nucleic Acid Therapeutics Market Report 2025" has been added to ResearchAndMarkets.com's offering. The Nucleic Acid Therapeutics Global Market Report 2025 offers an essential resource for... Full story